Brian O’Connor and Laura McCracken’s article, When Spin-Offs are Not Tax Free: Practical Tax Considerations for Life Sciences and Other High-Growth Businesses, 53 J. Corp. Tax’n (Nov./Dec. 2026) observes how tax-free treatment of spin-offs and asset separations in the pharmaceutical and life sciences sectors has become the exception rather than the rule. With this in mind, Brian and Laura, who specialize in mergers and acquisitions, offer practical insights for mitigating tax and evaluating alternative structures. Brian is a managing director in Andersen’s Philadelphia office, and Laura is a director in the Los Angeles office.